All lobbying filings

DLA PIPER LLP (US)

DLA PIPER LLP (US) filed a Q3 report for INDIVIOR INC. on October 16, 2025, reporting $60,000 in lobbying income.

Lobbying for INDIVIOR INC. · Pharmaceutical company

All filings by DLA PIPER LLP (US) · Everything INDIVIOR INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Medicaid Reentry Act, policies related to reimbursement of substance use disorder treatment.

Health Issues

General education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels.Issues related to access to addiction treatments, including telehealth.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.